Research Appraisalobservational

Extending Multiscale Characterization of Heart Rate Variability via Deep Learning for Mortality Risk Prediction

IEEE transactions on bio-medical engineeringKruse, Joao G S, Fujimoto, Yudai, Lee, Sinyoung et al.1 May 2026DOI

Clinical Snapshot

65CEBM
Evidence: Moderateobservational

PICO Framework

P — Population916 survivors and 70 nonsurvivors with 24-hour Holter ECG recordings
I — InterventionDetrended moving average (DMA) analysis combined with convolutional neural networks (CNNs)
C — ComparatorTraditional HRV metrics and clinical features
O — OutcomesMortality risk prediction, ROC-AUC, hazard ratios

Bottom Line

This prognostic study demonstrates that combining detrended moving average analysis with convolutional neural networks can improve mortality risk prediction from heart rate variability compared to traditional methods. The approach achieved moderate discriminative performance (ROC-AUC 0.72) and identified distinct physiological scaling patterns associated with survival. However, the study has significant limitations including a small number of mortality events, lack of external validation, and unclear follow-up methodology. While the novel analytical approach shows promise, the clinical utility remains uncertain without validation in independent cohorts and clearer definition of risk stratification thresholds. The complexity of the methodology may also limit practical implementation in routine clinical practice.

Evidence: Moderate

Key Findings

  • P Value: Not reported in abstract

  • Effect Size: Adjusted hazard ratio 2.129 for daytime recordings

  • Primary Outcome: Mortality risk prediction using DMA-CNN approach

  • Nnt Or Sensitivity: ROC-AUC 0.72 indicating moderate discriminative ability

  • Confidence Interval: Not reported in abstract

Clinical Application

Requires specialized DMA analysis software and CNN implementation, limiting immediate clinical adoption Could complement existing cardiac risk stratification tools used in Australian cardiology practice, though TGA approval would be needed for clinical implementation of the CNN algorithm Patients undergoing 24-hour Holter monitoring for cardiovascular risk assessment

Abstract

OBJECTIVE: To improve mortality risk prediction from heart rate variability (HRV) signals by capturing nonlinear scaling patterns often overlooked by traditional linear analyses. METHODS: This study combines detrended moving average (DMA) analysis with convolutional neural networks (CNNs). DMA curves were computed from 2-hour overlapping windows of 24-hour Holter ECG recordings in 916 survivors and 70 nonsurvivors. A CNN was trained to extract features from these curves and benchmarked against models using traditional HRV and clinical features. RESULTS: The CNN achieved an ROC-AUC of 0.72 and an adjusted hazard ratio of 2.129 for daytime recordings, outperforming standard models. Two patient groups emerged based on DMA scaling patterns. Group 1, with dominant short-term scaling, exhibited reduced slopes in nonsurvivors, suggesting impaired autonomic adaptability. Group 2 showed earlier transitions between short- and long-term behavior, where reduced long-term slopes more strongly predicted mortality. Integrated gradients analysis identified key timescales in the DMA curve driving model predictions. CONCLUSION: DMA combined with CNNs enhances HRV-based mortality risk stratification and reveals distinct physiological scaling patterns associated with survival outcomes. SIGNIFICANCE: This study highlights the potential of DMA and CNNs in improving mortality risk stratification and providing mechanistic insights into HRV dynamics, with implications for personalized health monitoring.

References

  1. 1.Kruse, J. G. S., Fujimoto, Y., Lee, S., Watanabe, E., & Kiyono, K. (2026). Extending multiscale characterization of heart rate variability via deep learning for mortality risk prediction. IEEE Transactions on Biomedical Engineering. https://doi.org/10.1109/TBME.2025.3614714
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service